Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 7Breast Neoplasms 4Sleep Initiation and Maintenance Disorders 3Motor Activity 2Leukemia 2Carcinoma, Non-Small-Cell Lung 2Vomiting 1Small Cell Lung Carcinoma 1Renal Insufficiency, Chronic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parasomnias 1Palliative Patients 1Neoplasms 1Nausea 1Liver Cirrhosis 1Heart Diseases 1Head and Neck Neoplasms 1Fatigue 1Coronary Artery Disease 1Chronic Pain 1Carcinoma, Hepatocellular 1Anxiety Disorders 1Agnosia 1

Interventions

Sorafenib 202lenvatinib 129Bevacizumab 124Nivolumab 85pembrolizumab 72atezolizumab 72Radiosurgery 71durvalumab 63Oxaliplatin 59sintilimab 57Fluorouracil 54Doxorubicin 44tislelizumab 43apatinib 43Leucovorin 40tremelimumab 37camrelizumab 37Radiofrequency Ablation 37Radiotherapy 36Magnetic Resonance Spectroscopy 32Capecitabine 30regorafenib 29Folfox protocol 29Cisplatin 28cabozantinib 26Hepatectomy 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25toripalimab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Hepatocellular × Breathing Exercises × Clear all
NCT04246970 2025-09-15

PreLiveR-T

Hospital Universitario La Fe

Phase NA Enrolling by invitation
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡